Int. J. Environ. Res. Public Health 2016, 13, 479; doi: /ijerph

Size: px
Start display at page:

Download "Int. J. Environ. Res. Public Health 2016, 13, 479; doi:10.3390/ijerph13050479"

Transcription

1 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S1 of S8 Supplementary aterials: Hospitalisation Resulting from edicine-related roblems in Adult atients with Cardiovascular iseases and iabetes in the United Kingdom and Saudi Arabia Abdullah Al Hamid, Zoe Aslanpour, Hisham Aljadhey and aisoon Ghaleb atient Table S1. Characteristics of Rs (n = 103) encountered in the UK study. Type Severity R N edicine Involved 1 oderate Chest pain, nausea and vomiting, sweating, Hyperkalaemia, continuous cough 1 ACEI (lisinopril 10 mg) ow Chest pain (due to unregulated dose, troponin level was too high) 1 3 oderate High blood sugar level 1 vomix 30 (short acting insulin) 4 oderate High blood sugar level, vomiting 1 Humulin 3 (Intermediate and long acting insulin) 5 oderate Cough Olanzapine 5 mg Ramipril 1.5 mg 6 oderate Uncontrolled blood pressure, Headache, palpitation 1 Telmisartan 80 mg oxazosin 8 mg 7 oderate Continuous high blood pressure, rising troponin level due to medication cardiotoxicity Amlodipine 10 mg Clopidogrel 75 mg (?) 8 ow 1 antus insulin 6U 9 ow High B 1 antus insulin 6U SC vorapid SC 10 oderate olyurea and polydipsia, ketoacidosis 1 etformin 1 g vorapid 4 8 u/day and u at lunch or dinner antus 8 u at evening 11 ow drowsiness, fall and head injury, confusion, dehydration and tachycardia 1 methadone 50 m dihydrocodeine 30 mg 1 oderate 1 Gliclazide 80 mg 13 p ow Near syncope, hypertension 1 oxazosin 8 mg Amlodipine 10 mg Atorvastatin 80 mg Ramipril 10 mg 14 oderate Hypertension, headache, dizziness 1 Temisartan 40 mg 15 oderate Angina, chest pain at rest, heavy ache down the left arm, tightness of jaw, nausea and vomiting 1 Nitrglycerine Isosorbide mononitrate 16 oderate Chest pain troponin negative 1 Isosorbide mononitrate

2 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S of S8 atient Table S1. Cont. Type Severity R N edicine Involved 17 oderate ild chest discomfort and exertion, Troponin level high 1 18 ow Chest pain, troponin level low 1 Nitroglycerine 19 oderate elena 1 0 Severe R bleeding and abdominal pain 1 ethotrexate 1.5 mg 1 Severe elena 1 Clopidogrel 75 mg oderate eranged liver function test 1 Atorvastatin 40 mg 3 oderate Hypotension 1 Ramipril.5 mg Spironolactone 5 mg 4 Severe Bleeding Confusion (potential) Antibiotic resistance (potential) Hypotension 4 Warfarin 3 mg/4 mg Ferrous fumarate igoxin 6.5 mg Quinine sulfate 300 mg Amlodipine 5 mg Spironolactone 5 mg 5 ow elena 1 6 ow Anaemia, chronic kidney disease, fluid overload which resulted in pulmonary oedema Ferrous fumarate Furosemide 7 ow Hypercalcemia 1 Calcium 8 oderate SOB, palpitation, abnormal TINR Bisoprolol 5 mg Warfarin 1 mg 9 ow Cough 1 30 Severe Haemoptysis 1 Warfarin 31 oderate alpitations 1 Amlodipine 5 mg 3 oderate Ankle swelling 1 Amlodipine 10 mg 33 ow Oedema 1 Furosemide 0 mg 34 oderate SOB 1 igoxin 35 oderate Hypoglycaemia 1 Insulin 36 oderate 37 oderate High blood pressure iarrhoea High B Glycosuria 3 Candesartan 4 mg Insulin Amoxicillin etformin 850 mg Gliclazide 160 mg ioglitasone 45 mg

3 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S3 of S8 atient Table S1. Cont. Type Severity R N edicine Involved 38 oderate Glycosuria 1 Gliclazide 160 mg etformine 1 g Humulin mix 5 39 oderate 1 etformin 500 mg 40 oderate 1 Insulatard 41 oderate 1 Glimipiride 4 oderate Renal failure 1 Spironolactone 43 oderate OR bleeding due to aspirin 1 Aspirin 44 oderate GOR 1 Aspirin 45 oderate Chest pain, SOB Aspirin GTN 46 oderate Sinus bradycardia 1 Bisoprolol 47 p oderate SOB, palpitation, abnormal TINR 1 Aspirin 48 ow worsening heart failure 1 Ramipril 1.5 mg 49 oderate Angina 1 Asassantin retard 50 oderate Impaired kidney function 1 Ramipril 51 oderate Hypoglycaemia 1 Gliclazide 80 mg 5 oderate Gastroenteritis 1 rednisolone 5 mg 53 oderate Stroke 1 54 Severe SOB, chest pain, sweating 1 isopyramide 300 mg 55 oderate aortic stenosis contraindication/ risk of hypotension 1 Isosorbide mononitrate 56 oderate 57 oderate 58 oderate palpitation atrial fibrillation NSTEI HF SOB in asthmatic patient ow systolic B 59 ow iarrhoea 1 1 osartan potassium 100 mg Atorvastatin 0 mg Ramipril 1.5 mg ropranolol 0 mg Indapamide.5 mg Nifedipine 40 mg oxonidine 30 mg Tiotropium 18 mcg Aminophylline 450 mg Salbutamol

4 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S4 of S8 atient Table S1. Cont. Type Severity R N edicine Involved 60 oderate Syncope 1 Glyceryl trinitrate 61 Severe 6, oderate 63 low SOB on exertion associated with chest pain ACS Bradycardia A (iver function tests) Eye sight loss 64 low Chest pain 1 1 atient stopped taking his medication Ticagrelor 90 mg Bisoprolol 1.5 mg Ezetimibe 10 mg Ramipril.5 mg Sotalol 40 mg Bisoprolol 1.5 mg Atorvastatin 80 mg Ramipril 1.5 mg 65 low Kidney function (low creatinine) 1 Ramipril 1.5 mg 66 low Chest pain 1 isinopril 10 mg 67 low Chest pain 1 Ramipril 7.5 mg 68 low Chest pain 1 Ramipril.5 mg 69 low Bleeding ulcer 1 Ferrous fumarate 305 mg 70,, oderate Increased INR iarrhoea Nausea, dizziness and weakness 3 Warfarin Antibiotic Warfarin and bisoprolol 1.5 mg 71 low Right leg swelling 1 Hydrocortisone 7 oderate ulmonary embolism 1 Warfarin 8.5 mg 73 oderate ulmonary embolism 1 Warfarin 8.5 mg 74 ow Hallucination 1 adopar 6.5 mg 75 low Tightness of chest and tachycardia 1 Glyceryl trinitrate 76 low Tachycardia 1 Salbutamol TT 77 low izziness and low blood pressure 1 Bisoprolol 10 mg 78 low Sinus rhythm 1 igoxin 79 low Tachycardia 1 Sotalol 80 mg 80 low Tachycardia 1 Sotalol 80 mg 81 low Hypoglycaemia 1 examethasone 8 low Hypotension 1 Atenolol 50 mg 83 low alpitation 1 ercandipine 10 mg

5 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S5 of S8 atient Table S1. Cont. Type Severity R N edicine Involved 84 low alpitation 1 oxazosin 4 mg Amlodipine 5 mg 85 low alpitation 1 ropafenone 150 mg 86 low alpitation 1 igoxin 15 mcg Bisoprolol 7.5 mg Table S. Characteristics of Rs encountered in the SA study. atient Type Severity R N edicine 1 High blood pressure isinopril 10 mg ercanidipine 0 mg Insulin mix etformine 500 mg 3 S Acute coronary syndrome 1 Simvastatin 0 mg 4 S 1 Humulin issing medicine 9 HTN vomix 30 Amlodipine 10 mg Bisoprolol 1.5 mg Ramipril 10 mg 10 1 etformin 500 mg 11 1 Insulin mix 1 1 etformin 1 g Insulin rapid 13 1 Insulin rapid 14 S Gastric bleeding 1 Aspirin 81 mg 15 1 Humalog mix 50:40 units etformin g 16 1 Insulin mix 17 1 Insulin mix etformin 500 mg 18 Anaemia 1 Iron 19 Cough 1 isinopril 10 mg

6 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S6 of S8 Table S. Cont. atient Type Severity R N edicine 0 S Sweating, nausea and vomiting increasing 1 evothyroxine 50 micrograms in intensity 1 HTN 1 Bisoprolol 1.5 mg 1 Glibenclamide 5 mg 3 HTN 1 Bisoprolol 5 mg 4 1 Insulin rapid 5 Cough 1 isinopril 10 mg 6 HTN 1 Bisoprolol 7.5 mg Furosemide 80 mg 7 Epigastric pain 1 8 Anaemia no iron intake Iron Glibenclamide 5 mg 9 1 vomix 30:14 units 30 Cough 1 31 Tachycardia 1 Thyroid hormone 3 Tachycardia 1 evothyroxin 100 mcg harm harm S S Hyperlipidaemia anaemia Epigastric pain Infection hyperglycaemia Gastroenteritis Simvastatin 0 mg issing medicine Insulatard Clopidogrel 75 mg Augmentin 500 mg etformin 500 mg Insulin mixtard 37 harm 1 issing medicine 38 harm 1 issing medicine 39 harm 1 Insulatard mix etformin 50 mg 40 Uncontrolled blood pressure Insulin mix Ramipril 1.5 mg 41 1 issing medicine 4 harm 1 issing medicine

7 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S7 of S8 Table S. Cont. atient Type Severity R N edicine 43 harm 1 Insulin NH Insulin regular 44 harm 1 issing medicine 45 1 issing medicine harm harm harm harm Elevated triglycerides Abdominal pain issing medicine issing medicine 48 harm 1 Glibenclamide 5 mg 49 harm 1 Insulin regular 50 harm 1 Insulin mix 51 1 issing medicine 5 harm 1 issing medicine 53 harm HTN 1 Bisoprolol 3.75 mg 54 harm issing medicines harm Elevated triglycerides 55 harm 1 Insulin mix 56 1 issing medicine 57 harm roductive cough/infection 1 Azithromycin 500 mg 58 harm Hypertension 1 etoprolol 1.5 mg 59 harm Anaemia 1 Iron Folic acid 5 mg 60 1 issing medicine 61 harm S Theophylline toxicity 6 Uncontrolled HTN 1 Gliclazide 160 mg Theophylline 150 mg Amlodipine 10 mg Furosemide 0 mg Isosorbide dinitrate 0 mg etoprolol 5 mg erindopril 5 mg 63 igitalis toxicity 1 igoxin 15 mcg 64 harm 1 Insulin mix

8 Int. J. Environ. Res. ublic Health 016, 13, 479; doi: /ijerph S8 of S8 Table S. Cont. atient Type Severity R N edicine 65 harm harm alpitations Insulin rapid etoprolol 5 mg 66 harm 1 Insulin mix 67 1 issing medicine 68 1 Insulin 69 1 Insulin mix 70 harm High cholesterol 1 Simvastatin 10 mg 71 harm Vomiting 1 Aspirin 34 mg 7 no harm Cough 1 Simvastatin 10 mg 73 Bradycardia 74 HTN 1 Insulin Tamsulosin 0.4 mg Nifedipine 30 mg Valsartan 160 mg 75 Hypoglycaemia 1 issing medicine 76 1 issing medicine 77 HTN 1 issing medicine 78 harm Orthopnoea 1 Aspirin 81 mg NA 79 1 Insulin rapid 80 S Gastric bleeding 1 81 HTN 1 isinopril 10 mg 8 Abdominal pain 1 Clopidogrel 75 mg 016 by the authors; licensee I, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (

Hypertension Guidelines

Hypertension Guidelines Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

ADVICE FOR PATIENTS ON HEART MEDICATIONS

ADVICE FOR PATIENTS ON HEART MEDICATIONS ADVICE FOR PATIENTS ON Contents: Introduction... 2 Drugs that ease chest pain... 4 Drugs that lower blood pressure... 6 Drugs that help an irregular heartbeat... 11 Drugs that lower Cholesterol... 14 Drugs

More information

Hypertension and Heart Failure Medications. Dr William Dooley

Hypertension and Heart Failure Medications. Dr William Dooley Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:

More information

Upstate University Health System Medication Exam - Version A

Upstate University Health System Medication Exam - Version A Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication

More information

CBT/OTEP 243 Aspirin Administration for ACS

CBT/OTEP 243 Aspirin Administration for ACS Seattle-King County EMS Seattle-King County Emergency Medical Services Division Public Health - Seattle/King County 401 5th Avenue, Suite 1200 Seattle, WA 98104 (206) 296-4693 February 2009 CBT/OTEP 243

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

Medicines for Heart Disease

Medicines for Heart Disease Medicines for Heart Disease There are many medicines to treat heart disease. Ask your doctor, nurse or pharmacist if you have questions about your medicines. Take medicines as directed. Do NOT stop taking

More information

Safety Information Card for Xarelto Patients

Safety Information Card for Xarelto Patients Safety Information Card for Xarelto Patients 15mg Simply Protecting More Patients 20mg Simply Protecting More Patients Keep this card with you at all times Present this card to every physician or dentist

More information

SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE

SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter.

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

Running Head: DISCHARGE PLANNING PROJECT

Running Head: DISCHARGE PLANNING PROJECT Running Head: DISCHARGE PLANNING PROJECT Discharge Planning Project Stephanie Skukalek Medical Surgical Nursing II Clinical University of South Florida 2 The patient I chose to do my discharge planning

More information

The 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015.

The 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015. Ontario Public Drug Programs, Ministry of Health and Long-Term Care Chronic-use Medications List by In accordance with subsection 18 (11.1) of Ontario Regulation 201/96 made under the Ontario Drug Benefit

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF

Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Leeds Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your

More information

GENERAL HEART DISEASE KNOW THE FACTS

GENERAL HEART DISEASE KNOW THE FACTS GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to

More information

Nurse Practitioner. CLINICAL PROTOCOL Chest Pain

Nurse Practitioner. CLINICAL PROTOCOL Chest Pain Nurse INTRODUCTION: Patients presenting with chest pain require rapid evaluation. Myocardial ischaemia should be considered in all patients presenting with chest pain. Assessment of pain type and referral,

More information

Initiate Atorvastatin 20mg daily

Initiate Atorvastatin 20mg daily Type 2 Diabetes Patient Objectives Stopping Smoking BMI > 25 kg m² Control BP to

More information

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is

More information

Essential Shared Care Agreement Drugs for Dementia

Essential Shared Care Agreement Drugs for Dementia Ref No. E040 Essential Shared Care Agreement Drugs for Dementia Please complete the following details: Patient s name, address, date of birth Consultant s contact details (p.3) And send One copy to: 1.

More information

A SHARED DECISION-MAKING PROGRAM TREATMENT CHOICES FOR CORONARY HEART DISEASE

A SHARED DECISION-MAKING PROGRAM TREATMENT CHOICES FOR CORONARY HEART DISEASE A SHARED DECISION-MAKING PROGRAM TREATMENT CHOICES FOR CORONARY HEART DISEASE This program content, including this booklet is copyright protected by Health Dialog Services Corporation (HDSC), a related

More information

Cardiovascular diseases. pathology

Cardiovascular diseases. pathology Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

Returning to fitness after a coronary stent procedure

Returning to fitness after a coronary stent procedure Returning to fitness after a coronary stent procedure A patient s guide 1 Returning to fitness after a coronary stent procedure The first few days and weeks following your discharge from Papworth Hospital

More information

SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions

SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions With Dickinson College s Value Based Insurance Design (VBID) If you have an ongoing condition, you can live well. You will need to

More information

(TECHNICIANS) 4:30-5:30PM

(TECHNICIANS) 4:30-5:30PM E5. HIGH RISK PATIENTS, HIGH RISK MEDICATIONS: A FOCUS ON ANTICOAGULATION AND HEART FAILURE (TECHNICIANS) 4:30-5:30PM ACPE UAN: 0107-9999-15-040-L01-T 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning

More information

Cardiac Rehabilitation

Cardiac Rehabilitation Cardiac Rehabilitation Introduction Experiencing heart disease should be the beginning of a new, healthier lifestyle. Cardiac rehabilitation helps you in two ways. First, it helps your heart recover through

More information

Medication Review. What is Diabetes? Medications. Michelle Weddell. Business Development Executive Clinical Specialist Podiatrist

Medication Review. What is Diabetes? Medications. Michelle Weddell. Business Development Executive Clinical Specialist Podiatrist Medication Review Michelle Weddell Business Development Executive Clinical Specialist Podiatrist What is Diabetes? What is a type 1 diabetic? What is type 2 diabetic? Is there other forms of diabetes?

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

A Patients Guide to Heart Failure

A Patients Guide to Heart Failure A Patients Guide to Heart Failure Exceptional healthcare, personally delivered Heart Failure The term heart failure means that your heart is weakened and is having difficulty in pumping as hard as it would

More information

Common Medication for People Receiving Haemodialysis

Common Medication for People Receiving Haemodialysis Common Medication for People Receiving Haemodialysis Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS)

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS) A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get

More information

Acquired Heart Disease: Prevention and Treatment

Acquired Heart Disease: Prevention and Treatment Acquired Heart Disease: Prevention and Treatment Prevention and Treatment Sharon L. Roble, MD Assistant Professor Adult Congenital Heart Program The Ohio State University/Nationwide Children s Hospital

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine) PACKAGE LEAFLET: INFORMATION FOR THE USER ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection Adrenaline (Levorenine, Epinephrine) Read all of this leaflet carefully before you start using this

More information

Instruct patient to: Take own pulse before taking medication Withhold medication and notify health care provider if pulse is greater than 100

Instruct patient to: Take own pulse before taking medication Withhold medication and notify health care provider if pulse is greater than 100 Nursing Process Focus: Patients Receiving Levothyroxine (Synthroid) Potential Nursing Diagnoses Tissue perfusion, Risk for Ineffective related to tachycardia secondary to adverse effects of drug therapy

More information

Human Normal Immunoglobulin Solution for Intravenous Infusion.

Human Normal Immunoglobulin Solution for Intravenous Infusion. CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM Human Normal Immunoglobulin Solution for Intravenous Infusion. OCTAGAM is available in single use bottles of 20 ml, 50 ml, 100 ml and 200 ml. OCTAGAM contains

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,

More information

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Primary Care Management of Women with Hyperlipidemia Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Objectives: Define dyslipidemia in women Discuss the investigation process leading

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

ACUTE STROKE UNIT ORIENTATION

ACUTE STROKE UNIT ORIENTATION ACUTE STROKE UNIT ORIENTATION 2014 TEACHING YOUR STROKE PATIENTS ABOUT THEIR MEDICATION Please refer to Module 8: Secondary Stroke Prevention for additional information Blood Pressure Medication Angiotensin

More information

Introduction to Atrial Fibrillation (AFib)

Introduction to Atrial Fibrillation (AFib) Introduction to Atrial Fibrillation (AFib) Learn About: 1. What is atrial fibrillation? 2. How will I feel? 3. Who gets AFib? 4. Risk of stroke 5. AFib treatment 6. How to live well with AFib 1. What is

More information

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA 1. PRODUCT IDENTIFICATION DOCUMENTATION In order to be eligible for compensation under the Settlement Agreement, each Claimant must provide evidence of the Class

More information

CHAPTER 8 ANTIHYPERTENSIVE DRUGS

CHAPTER 8 ANTIHYPERTENSIVE DRUGS CHAPTER 8 ANTIHYPERTENSIVE DRUGS Classification 1. Diuretics. 2. Beta adrenergic blockers. 3. Calcium channel blockers. 4. Angiotensin converting enzyme inhibitors. 5. Angiotensin receptor blockers. 6.

More information

Atrial Fibrillation Management Across the Spectrum of Illness

Atrial Fibrillation Management Across the Spectrum of Illness Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,

More information

Medicines for your heart

Medicines for your heart Medicines for your heart About the British Heart Foundation As the nation s heart charity, we have been funding cutting-edge research that has made a big difference to people s lives. But the landscape

More information

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation

More information

Atrial fibrillation/flutter: When to refer, What tests, What meds

Atrial fibrillation/flutter: When to refer, What tests, What meds Atrial fibrillation/flutter: When to refer, What tests, What meds Warren Smith Green Lane Cardiovascular Service Auckland City Hospital, Auckland, New Zealand Why might it not be a good idea to cardiovert

More information

Cardioversion for. Atrial Fibrillation. Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation

Cardioversion for. Atrial Fibrillation. Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation Cardioversion for Atrial Fibrillation Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation When You Have Atrial Fibrillation You ve been told you have a heart condition called atrial

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing! ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or

More information

Common Causes of Fluctuating Blood Pressure. When Fluctuating Blood Pressure Readings are Normal

Common Causes of Fluctuating Blood Pressure. When Fluctuating Blood Pressure Readings are Normal Common Causes of Fluctuating Blood Pressure One in three Americans has high blood pressure. Blood pressure is the measurement of the force of the blood against the walls of the arteries. There are several

More information

Amlodipine 5 and 10 mg tablets

Amlodipine 5 and 10 mg tablets Package leaflet: Information for the patient Amlodipine Apotex 5 mg tablets Amlodipine Apotex 10 mg tablets Amlodipine besilate Read all of this leaflet carefully before you start taking this medicine

More information

Sudden dizziness, trouble walking, loss of balance or coordination

Sudden dizziness, trouble walking, loss of balance or coordination rivaroxaban (Xarelto) Patient Education Information Sheet Veterans Health System Pharmacy Service 119 What is rivaroxaban (Xarelto)? A new anticoagulant ( blood thinner ) that reduces the risk of stroke

More information

Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier

Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Most common dysrhythmia seen in ED, and incidence increasing with ageing population Presentation Common presentations: younger patients often

More information

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs

More information

Protocol for the management of atrial fibrillation in primary care

Protocol for the management of atrial fibrillation in primary care Protocol for the management of atrial fibrillation in primary care Protocol for the management of atrial fibrillation in primary care Contents Page no Definition 2 Classification of AF 2 3 Identification

More information

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes

More information

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181

More information

Dallas Neurosurgical and Spine Associates, P.A Patient Health History

Dallas Neurosurgical and Spine Associates, P.A Patient Health History Dallas Neurosurgical and Spine Associates, P.A Patient Health History DOB: Date: Reason for your visit (Chief complaint): Past Medical History Please check corresponding box if you have ever had any of

More information

Atrial Fibrillation. Patient Information. 828361 Dec 19-12

Atrial Fibrillation. Patient Information. 828361 Dec 19-12 Atrial Fibrillation Patient Information 828361 Dec 19-12 Contents Introduction 1 Treatment & decrease stroke options 2 Information for people who are taking warfarin (Coumadin ) 5 Information for people

More information

Breast Cancer. Breast Cancer Page 1

Breast Cancer. Breast Cancer Page 1 Breast Cancer Summary Breast cancers which are detected early are curable by local treatments. The initial surgery will give the most information about the cancer; such as size or whether the glands (or

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr ENTRESTO TM sacubitril/valsartan film-coated tablets Read this carefully before you start taking ENTRESTO TM and

More information

Case Presentation: Mr. E.M. Dr. Braun

Case Presentation: Mr. E.M. Dr. Braun Case Presentation: Mr. E.M. Dr. Braun Case Presentation: Mr. E.M. 66 years old; PMHx CAD with stent 2010; carotid artery disease with stent 1999; aortic stenosis; CVA 1998; type 2 DM; colon cancer with

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user LOSARTAN POTASSIUM 25 mg FILM-COATED TABLETS LOSARTAN POTASSIUM 50 mg FILM-COATED TABLETS LOSARTAN POTASSIUM 100 mg FILM-COATED TABLETS Losartan Potassium Read

More information

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

patient group direction

patient group direction DICLOFENAC v01 1/8 DICLOFENAC PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner

More information

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.

More information

Department of Cardiology Royal Berkshire Hospital. Heart Failure. Information for patients

Department of Cardiology Royal Berkshire Hospital. Heart Failure. Information for patients Department of Cardiology Royal Berkshire Hospital Heart Failure Information for patients Introduction Heart failure can be caused by various heart conditions, which can be treated in different ways, to

More information

Living with. Atrial Fibrillation

Living with. Atrial Fibrillation Living with Atrial Fibrillation U nderstanding Atrial Fibrillation An estimated 2.7 million Americans are living with atrial fibrillation (AF). That makes it the most common heart rhythm abnormality in

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

Perioperative Medication Management

Perioperative Medication Management CARDIOVASCULAR Beta blockers (metoprolol, atenolol, others) Should be continued until and including the day of Ace inhibitors (ACEI) & Angiotensin receptor blockers (ARB) (captopril, lisinopril, losartan,

More information

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Read this Patient Information carefully before you start taking VYTORIN and each time you get a refill. There may be new information.

More information

Treatment with Rivaroxaban

Treatment with Rivaroxaban UW MEDICINE PATIENT EDUCATION Treatment with Rivaroxaban Xarelto This handout explains the medicine rivaroxaban, a drug that helps prevent blood clots. What is rivaroxaban? Rivaroxaban (brand name Xarelto)

More information

Diabetic Emergencies. David Hill, D.O.

Diabetic Emergencies. David Hill, D.O. Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment

More information

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including: MEDGUIDE SECTION Medication Guide SEROQUEL (SER-oh-kwell) (quetiapine fumarate) Tablets Read this Medication Guide before you start taking SEROQUEL and each time you get a refill. There may be new information.

More information

Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation

Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation On the following pages are a number of questions asking about the conditions under which you would prescribe anticoagulation

More information

Notice from the Executive Officer: Supporting Sustainability and Access for the Ontario Drug Benefit Program

Notice from the Executive Officer: Supporting Sustainability and Access for the Ontario Drug Benefit Program Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Supporting Sustainability and Access for the Ontario Drug Benefit Program Responsible management of

More information

Brand Name Marevan Pradaxa Xarelto Eliquis

Brand Name Marevan Pradaxa Xarelto Eliquis Medicines for stroke prevention in atrial fibrillation Choosing the right one for you Atrial fibrillation (AF) is a condition that affects the heart, causing it to beat irregularly and too fast. When this

More information

Zomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION

Zomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION Zomig Nasal Spray Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about It does not contain all

More information

ACLS PHARMACOLOGY 2011 Guidelines

ACLS PHARMACOLOGY 2011 Guidelines ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.

More information

Presenting the SUTENT Patient Call Center.

Presenting the SUTENT Patient Call Center. Presenting the SUTENT Patient Call Center. Please see patient Medication Guide and full prescribing information attached. We re here to support you. Dealing with cancer is a journey. Along the way, you

More information

Heart Failure: Diagnosis and Treatment

Heart Failure: Diagnosis and Treatment Heart Failure: Diagnosis and Treatment Approximately 5 million people about 2 percent of the U.S. population are affected by heart failure. Diabetes affects 20.8 million Americans and 65 million Americans

More information

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know Acute Coronary Syndrome What Every Healthcare Professional Needs To Know Background of ACS Acute Coronary Syndrome (ACS) is an umbrella term used to cover a spectrum of clinical conditions that are caused

More information

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular

More information

Living with a Non-Vitamin K Antagonist Oral Anticoagulant (NOAC)

Living with a Non-Vitamin K Antagonist Oral Anticoagulant (NOAC) Living with a Non-Vitamin K Antagonist Oral Anticoagulant (NOAC) dabigatran (Pradaxa ) rivaroxaban (Xarelto ) apixaban (Eliquis ) Information for patients Produced and made available by the Western Australian

More information

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.

More information

A PATIENT S GUIDE TO STROKE AND ATRIAL FIBRILLATION (AF)

A PATIENT S GUIDE TO STROKE AND ATRIAL FIBRILLATION (AF) A PATIENT S GUIDE TO STROKE AND ATRIAL FIBRILLATION (AF) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects,

More information

PIAX PLUS ASPIRIN 75/100 Film-Coated Tablets contains the active ingredients clopidogrel and aspirin

PIAX PLUS ASPIRIN 75/100 Film-Coated Tablets contains the active ingredients clopidogrel and aspirin PIAX PLUS ASPIRIN 75/100 Film-Coated Tablets contains the active ingredients clopidogrel and aspirin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about

More information

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you

Medicines for stroke prevention in atrial fibrillation. Choosing the right one for you Medicines for stroke prevention in atrial fibrillation Choosing the right one for you Atrial fibrillation (AF) is a condition that affects the heart, causing it to beat irregularly and too fast. When this

More information

Fainting - Syncope. This reference summary explains fainting. It discusses the causes and treatment options for the condition.

Fainting - Syncope. This reference summary explains fainting. It discusses the causes and treatment options for the condition. Fainting - Syncope Introduction Fainting, also known as syncope, is a temporary loss of consciousness. It is caused by a drop in blood flow to the brain. You may feel dizzy, lightheaded or nauseous before

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

National Cancer Institution (NCI) Toxicity Criteria

National Cancer Institution (NCI) Toxicity Criteria National Cancer Institution (NCI) Toxicity Criteria Toxicity Grade 0 1 2 3 4 Blood/Bone Marrow WBC?4.0 3.0-3.9 2.0-2.9 1.0-1.9

More information

Inform the patient early of the need for multiple medications

Inform the patient early of the need for multiple medications September 2005 PPR thirty one Prescribing Practice Review PPR For General Practice Ischaemic heart disease Key messages Inform the patient early of the need for multiple medications Use the simplest possible

More information

Vascular Risk Reduction: Addressing Vascular Risk

Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have

More information

1. What Olanzapine Tablets is and what it is used for

1. What Olanzapine Tablets is and what it is used for PACKAGE LEAFLET: INFORMATION FOR THE USER Olanzapine 2.5 mg Film-coated Tablets Olanzapine 5 mg Film-coated Tablets Olanzapine 7.5 mg Film-coated Tablets Olanzapine 10 mg Film-coated Tablets Olanzapine

More information

SYNACTHEN i.m./i.v. tetracosactide hexaacetate

SYNACTHEN i.m./i.v. tetracosactide hexaacetate New Zealand Consumer Medicine Information SYNACTHEN i.m./i.v. tetracosactide hexaacetate 250 micrograms/ml solution for injection or infusion What is in this leaflet This leaflet answers some common questions

More information

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet

More information